PacBio

How long-read sequencing builds the foundation for AI-driven biopharma

Artificial intelligence is reshaping nearly every stage of drug discovery and development. From identifying new therapeutic targets to predicting protein function, designing therapeutics, and improving patient stratification, AI has... This content originally appeared on pacb.com

Measuring – not guessing – the true path

Over the past ~15 years, several attempts were made to adapt short-read sequencing to capture longer-distance information, including 10X Genomics linked reads, Illumina TruSeq synthetic long reads, and Illumina... This content originally appeared on pacb.com

Customer success story: How CHU Nîmes went from install to routine rare disease use in three months

For many genetics labs, the road from instrument installation to routine use consists of long months of validation, workflow development, and institutional sign-off. Dr. Claire Guissart, head of the... This content originally appeared on pacb.com

APAC PRISM 2026 highlights: Advancing research with HiFi sequencing

We are excited to share highlights from the 2026 APAC PRISM event, held this year in Fukuoka, Japan. Located near Canal City, this PRISM event offered attendees the opportunity... This content originally appeared on pacb.com

The practical value of long-range PCR for targeted HiFi sequencing

For clinical research laboratories evaluating long-read sequencing, the central question is often not whether longer reads are useful. The value is clearest in the places where conventional approaches have... This content originally appeared on pacb.com

Meet the winner of the 2026 SMRT Grant for long-read cancer multiomics for clinical research and drug discovery

Cancer genomics is one of the most complex and consequential areas in all of life sciences. The genetic and epigenetic changes that drive tumor development, progression, and treatment resistance... This content originally appeared on pacb.com